Ftse Mib
33.798,31
0,50%
DAX
18.042,70
0,27%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
64.412,86
0,65%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Autolus Therapeutics PLC (AUTL) Autolus Therapeutics PLC (AUTL) Notizie

Autolus Therapeutics PLC

AUTL
4,19
0,00 (0,00%)
06 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/4/202416:00GLOBEAbstract for longer-term follow-up and additional data..
23/4/202413:00GLOBEAutolus Therapeutics to Report First Quarter 2024 Financial..
02/4/202413:00GLOBEAutolus Therapeutics announces acceptance of Marketing..
01/4/202413:00GLOBEAutolus Therapeutics Announces Changes to its Board of..
14/3/202412:00GLOBEAutolus Therapeutics Reports Full Year 2023 Financial..
12/3/202412:00GLOBEAutolus Therapeutics receives Medicines and Healthcare..
11/3/202412:00GLOBEAutolus Therapeutics announces publication in Blood Cancer..
29/2/202413:00GLOBEAutolus Therapeutics to Report Full Year 2023 Financial..
23/2/202423:28EDGAR2Form D - Notice of Exempt Offering of Securities
22/2/202413:00GLOBEAutolus Therapeutics announces publication in Nature..
21/2/202423:01EDGAR2Form SC 13D - General statement of acquisition of beneficial..
14/2/202414:37EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202423:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/2/202422:17EDGAR2Form 8-K - Current report
08/2/202413:00GLOBEAutolus Announces Pricing of Underwritten Offering
08/2/202412:06EDGAR2Form 8-K - Current report
08/2/202411:45GLOBEBioNTech and Autolus Announce Strategic CAR-T Cell Therapy..
08/2/202404:00EDGAR2Form S-3ASR - Automatic shelf registration statement of..
31/1/202422:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/1/202419:02EDGAR2Form 8-K - Current report
23/1/202413:00GLOBEAutolus Therapeutics announces publication in ACS Chemical..
22/1/202413:54DJNAutolus Therapeutics Gets BLA Acceptance for Obecabtagene..
22/1/202413:00GLOBEAutolus Therapeutics announces acceptance of Biologics..
10/1/202421:12EDGAR2Form 8-K - Current report
10/1/202413:00GLOBEAutolus Therapeutics announces the appointment of Robert W...
22/12/202314:24EDGAR2Form 8-K - Current report
22/12/202313:00GLOBEAutolus Therapeutics Announces Changes to its Board of..
11/12/202314:31EDGAR2Form 8-K - Current report
10/12/202302:30GLOBEAutolus Therapeutics Presents Clinical Data Updates at the..
28/11/202320:59DJNCabaletta Bio Down as FDA Looks Into Issues With Several..
27/11/202313:54DJNAutolus Seeks FDA OK of Obe-Cel in Adult B-Cell Acute..
27/11/202313:07EDGAR2Form 8-K - Current report
27/11/202313:00GLOBEAutolus Therapeutics Submits Biologics License Application..
15/11/202313:00GLOBEAutolus Therapeutics to Host Analyst / Investor event at the..
09/11/202322:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:18EDGAR2Form 8-K - Current report
06/11/202313:00GLOBEAutolus Therapeutics announces participation in upcoming..
03/11/202321:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
02/11/202321:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/11/202314:00GLOBEAutolus Therapeutics to Present Clinical Data Updates at the..
02/11/202312:11GLOBEAutolus Therapeutics Reports Third Quarter 2023 Financial..
17/10/202313:00GLOBEAutolus Therapeutics to host virtual event to discuss the..
11/10/202314:07GLOBECorrection - Autolus Therapeutics to report third quarter..
11/10/202313:00GLOBEAutolus Therapeutics to report third quarter 2023 financial..
05/9/202313:00GLOBEAutolus Therapeutics announces data from AUTO1/22 trial in..
07/8/202322:57EDGAR2Form S-8 - Securities to be offered to employees in employee..
03/8/202322:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/8/202313:00GLOBEAutolus Therapeutics Reports Second Quarter 2023 Financial..
21/7/202322:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/7/202313:00GLOBEAutolus Therapeutics to report second quarter 2023 financial..
Apertura: Min: Max:
Chiusura: 4,19

La tua Cronologia

NASDAQ
AUTL
Autolus Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network